The Plasmodium berghei sexual stage antigen PSOP12 induces anti-malarial transmission blocking immunity both in vivo and in vitro.
Anti-malarial transmission-blocking vaccines (TBVs) aim to inhibit the transmission of Plasmodium from humans to mosquitoes by targeting the sexual/ookinete stages of the parasite. Successful use of such interventions will subsequently result in reduced cases of malarial infection within a human pop...
Main Authors: | Sala, K, Nishiura, H, Upton, L, Zakutansky, SE, Delves, M, Iyori, M, Mizutani, M, Sinden, R, Yoshida, S, Blagborough, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2015
|
Similar Items
-
Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites.
by: Mizutani, M, et al.
Published: (2014) -
Plasmodium berghei HAP2 induces strong malaria transmission-blocking immunity in vivo and in vitro.
by: Blagborough, A, et al.
Published: (2009) -
A high-throughput assay for the identification of malarial transmission-blocking drugs and vaccines
by: Delves, M, et al.
Published: (2012) -
A high-throughput assay for the identification of malarial transmission-blocking drugs and vaccines.
by: Delves, M, et al.
Published: (2012) -
Maintenance of the Plasmodium berghei life cycle.
by: Sinden, R, et al.
Published: (2002)